NIR-light-mediated spatially selective triggering of anti-tumor immunity via upconversion nanoparticle-based immunodevices

Abstract

Immunomodulatory therapies are becoming a paradigm-shifting treatment modality for cancer. Despite promising clinical results, cancer immunotherapy is accompanied with off-tumor toxicity and autoimmune adverse effects. Thus, the development of smarter systems to regulate immune responses with superior spatiotemporal precision and enhanced safety is urgently needed. Here we report an activatable engineered immunodevice that enables remote control over the antitumor immunity in vitro and in vivo with near-infrared (NIR) light. The immunodevice is composed of a rationally designed UV light-activatable immunostimulatory agent and upconversion nanoparticle, which acts as a transducer to shift the light sensitivity of the device to the NIR window. The controlled immune regulation allows the generation of effective immune response within tumor without disturbing immunity elsewhere in the body, thereby maintaining the antitumor efficacy while mitigating systemic toxicity. The present work illustrates the potential of the remote-controlled immunodevice for triggering of immunoactivity at the right time and site.

Size-selective molecular recognition based on a confined DNA molecular sieve using cavity-tunable framework nucleic acids

“…Though these methods have made some progress, they failed the selective and accurate biosensing for some biological targets in a specific situation where the properties of targets and analogues (such as nucleic acids sequences) are too similar to be distinguished. For example, although a number of intracellular microRNAs (miRNAs) biosensors have been developed based on sequence complementarity of miRNAs and nucleic acid probes [8][9][10][11][12][13][14] , their detection accuracy for mature miRNAs is affected by the presence of its precursor (precursor microRNAs, abbreviated as pre-miRNAs) since the sequence of mature miR-NAs is also present in the precursors. Alternatively, considering the different length of mature miRNAs (19-23 nt) and pre-miRNAs (60-70 nt) 15 , a size-selective molecular strategy based on the size difference between targets and non-targets is promising.…”

Combating Implant Infections: Shifting Focus from Bacteria to Host

“…This system allows very precise spatiotemporal control of the immunomodulatory activity with near-infrared light. [357] Wang et al developed an Figure 5. Coating designs and representative drug release profiles.…”

Water‐Splitting Based and Related Therapeutic Effects: Evolving Concepts, Progress, and Perspectives

“…However, biomedical applications of UV light are nor preferable for its severe damages to biological tissues and lim ited penetration. [33] However, the much preferred red or infrared (>650 nm) light often cannot provide sufficient energies for effective watersplitting. To overcome this issue, Chen et al…”